Correlations of soluble TRAILR4, white blood cell count, and 25-hydroxyvitamin D with acute upper respiratory infection in children

Lianfang  Wu; Zhengjie  Chen; Jiakai Hu

doi:10.2298/VSP240426039W

Lianfang Wu Ningbo Yinzhou No. 2 Hospital, Department of Pediatrics, Ningbo, Zhejiang Province, China
Zhengjie Chen Ningbo Yinzhou No. 2 Hospital, Department of Pediatrics, Ningbo, Zhejiang Province, China
Jiakai Hu Ningbo Yinzhou No. 2 Hospital, Department of Pediatrics, Ningbo, Zhejiang Province, China

DOI: https://doi.org/10.2298/VSP240426039W

Keywords: child;, leukocytes;, respiratory tract infections;, tumor necrosis factor – alpha;, vitamin d

Abstract

Background/Aim. Rapid diagnosis and treatment guidance for acute upper respiratory infection (AURI) are challenging due to difficulties in specimen collection and the need for advanced laboratory conditions. The aim of this study was to investigate the correlations between soluble tumor necrosis factor-related apoptosis-inducing ligand receptor 4 (sTRAILR4), white blood cell (WBC) count, and 25-hydroxyvitamin D [25(OH)D] with AURI in children. Methods. A total of 80 children with AURI treated from January 2022 to January 2023 were enrolled in the study group. Another 80 healthy children undergoing physical examinations during the same period were enrolled in the control group. The levels of serum sTRAILR4 and 25(OH)D, and WBC count were measured. Receiver operating characteristic (ROC) curves were plotted to analyze the predictive values of serum sTRAILR4 and 25(OH)D levels and WBC count for AURI. Unconditional logistic stepwise regression analysis was employed for multivariate analysis. Results. Compared with the control group, the study group had a significantly elevated level of sTRAILR4 and WBC count and a reduced level of 25(OH)D (p < 0.05). The areas under the ROC curves of sTRAILR4 and 25(OH)D levels, and WBC count were 0.893, 0.765, and 0.937, respectively, suggesting that they were predictors of AURI. An elevated level of sTRAILR4 (≥ 88.751 pg/mL), elevated WBC count (≥ 10.223 × 10⁹/L), along with a reduced level of 25(OH)D (≤ 48.943 nmol/L), were identified as significant influencing factors for AURI (p < 0.05). The level of sTRAILR4 and WBC count were positively correlated with AURI, while the 25(OH)D level had a negative correlation (p < 0.05). Conclusion. The children with AURI have a significantly higher level of sTRAILR4 and WBC count and a lower level of 25(OH)D than healthy children. In addition to WBC, sTRAILR4 and 25(OH)D may have a role in the assessment of pediatric upper respiratory infection.

References

Ibraimi Q, Bajrami S, Zenuni A, Aliji A. Treatment of upper respiratory tract infections with third generation cefalosporine in preschool children. Int J Med Sci 2022; 7(13–4): 143–8.

Jin X, Ren J, Li R, Gao Y, Zhang H, Li J, et al. Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019. EClinicalMedicine 2021; 37: 100986.

Gan Y, Hu Y, Dong H, Wu L, Niu Y. Causes of Lower Respir-atory Tract Infections and the Use of Diagnostic Biomarkers in Blood Samples from Children in Hohhot, Inner Mongolia, China, Between July 2019 and June 2020. Med Sci Monit 2022; 28: e934889.

Wu J, Wang X, Zhou M, Chen GB, Du J, Wang Y, et al. The value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in differentiating pneumonia from upper respiratory tract infection (URTI) in children: a cross-sectional study. BMC Pediatr 2021; 21(1): 545.

Russell CD, Parajuli A, Gale HJ, Bulteel NS, Schuetz P, de Jager CPC, et al. The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and me-ta-analysis. J Infect 2019; 78(5): 339–48.

Li Y, Min L, Zhang X. Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) levels in the differential diagnosis of acute bacterial, viral, and myco-plasmal respiratory tract infections in children. BMC Pulm Med 2021; 21(1): 386.

Van Houten C, van de Maat JS, Naaktgeboren C, Bont L, Oosten-brink R. Update of a clinical prediction model for serious bac-terial infections in preschool children by adding a host-protein-based assay: a diagnostic study. BMJ Paediatr Open 2019; 3(1): e000416.

Zoccali C, Tripepi G, Stel V, Fu EL, Mallamaci F, Dekker F, et al. Decoy receptors as biomarkers for exploring aetiology and designing new therapies. Clin Kidney J 2024; 17(8): sfae222.

Xu Y, Baylink DJ, Chen CS, Reeves ME, Xiao J, Lacy C, et al. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treat-ment for COVID-19. J Transl Med 2020; 18(1): 322.

Jolliffe DA, Camargo CA Jr, Sluyter JD, Aglipay M, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data. Lancet Diabetes Endocrinol 2025; S2213-8587(24)00348-6.

Murgia V, Manti S, Licari A, De Filippo M, Ciprandi G, Marseglia GL. Upper Respiratory Tract Infection-Associated Acute Cough and the Urge to Cough: New Insights for Clini-cal Practice. Pediatr Allergy Immunol Pulmonol 2020; 33(1): 3–11.

Garaiova I, Paduchová Z, Nagyová Z, Wang D, Michael DR, Plum-mer SF, et al. Probiotics with vitamin C for the prevention of upper respiratory tract symptoms in children aged 3-10 years: randomised controlled trial. Benef Microbes 2021; 12(5): 431–40.

Luo C, Yang Y, Li P, Chen X, Cai M, Wang Y. Effect of nurse-ry on asthma and acute upper respiratory infection in healthy preschool children. Postepy Dermatol Alergol 2022; 39(4): 675–81.

Plotnikova MA, Klotchenko SA, Lebedev KI, Lozhkov AA, Tar-askin AS, Gyulikhandanova NE, et al. Antibody microarray im-munoassay for screening and differential diagnosis of upper respiratory tract viral pathogens. J Immunol Methods 2020; 478: 112712.

Yin H, Mo S. Value of combined detection of serum amyloid A, C-reactive protein and procalcitonin in differential diagno-sis of respiratory tract infection in children of China. Ann Med 2022; 54(1): 1732–7.

Seyit M, Avci E, Nar R, Senol H, Yilmaz A, Ozen M, et al. Neu-trophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med 2021; 40: 110–4.

Cioffi L, Limauro R, Sassi R, Boccazzi A, Del Gaizo D. De-creased Antibiotic Prescription in an Italian Pediatric Popula-tion With Nonspecific and Persistent Upper Respiratory Tract Infections by Use of a Point-of-Care White Blood Cell Count, in Addition to Antibiotic Delayed Prescription Strategy. Glob Pediatr Health 2016; 3: 2333794X15615771.

Kotelkin A, Prikhod'ko EA, Cohen JI, Collins PL, Bukreyev A. Respiratory syncytial virus infection sensitizes cells to apopto-sis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Virol 2003; 77(17): 9156–72.

Papan C, Argentiero A, Adams O, Porwoll M, Hakim U, Farinelli E, et al. Association of viral load with TRAIL, IP-10, CRP biomarker signature and disease severity in children with res-piratory tract infection or fever without source: A prospec-tive, multicentre cohort study. J Med Virol 2023; 95(1): e28113.

Nielsen NM, Junker TG, Boelt SG, Cohen AS, Munger KL, Sten-ager E, et al. Vitamin D status and severity of COVID-19. Sci Rep 2022; 12(1): 19823. Erratum in: Sci Rep 2023; 13(1): 1781.

Zisi D, Challa A, Makis A. The association between vitamin D status and infectious diseases of the respiratory system in in-fancy and childhood. Hormones (Athens) 2019; 18(4): 353–63.

Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients 2020; 12(4): 988.

Jolliffe DA, Holt H, Greenig M, Talaei M, Perdek N, Pfeffer P, et al. Effect of a test-and-treat approach to vitamin D supple-mentation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORO-NAVIT). BMJ 2022; 378: e071230.